Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Accepts healthy volunteers Results available

A Study to Evaluate the Shedding and Safety of Trivalent Influenza Virus Vaccine Live, Intranasal in Infants and Young Children

ClinicalTrials.gov ID: NCT00344305

Public ClinicalTrials.gov record NCT00344305. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 24, 2026, 2:05 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Open-Label, Single Arm Trial to Evaluate the Shedding and Safety of CAIV-T Administered to Children 6 to Less Than 60 Months of Age

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Open label, single arm, multicenter study of the shedding and safety of a single dose of trivalent, influenza virus vaccine live, intranasal in children 6 to \< 60 months of age, with 28-day shedding follow-up and 180-day safety follow-up.

Study identification

NCT ID
NCT00344305
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
MedImmune LLC
Industry
Enrollment
200 participants

Conditions and interventions

Conditions

Interventions

Biological

Eligibility (public fields only)

Age range
6 Months to 59 Months
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 1, 2006 (Actual)
Primary completion
Jul 1, 2006 (Actual)
Completion
Dec 1, 2006 (Actual)
Last update posted
Jul 24, 2017

2006

United States locations

U.S. sites
16
U.S. states
10
U.S. cities
16
Facility City State ZIP Site status
Little Rock Allergy & Asthma Clinic, PA Little Rock Arkansas 72205 —
Pediatric and Adolescent Medicine, PA (PAMPA) Marietta Georgia 30062 —
Kentucky Pediatrics/Adult Research Bardstown Kentucky 40004 —
Benchmark Research Metairie Louisiana 70006 —
Health Sciences Research Center Cortland New York 13045 —
Health Sciences Research Center Elmira New York 14901 —
Regional Clinical Research Inc. Endwell New York 13760 —
Grand Prairie Pediatrics & Allergy Clinic Oklahoma City Oklahoma 73132 —
Primary Physicians Research , Inc Pittsburgh Pennsylvania 15241 —
Med-Pro Research Inc. Houston Texas 77004 —
Central Texas Health Research New Braunfels Texas 78130 —
Benchmark Research San Angelo Texas 76904 —
Wee Care Pediatrics Layton Utah 84041 —
Utah Valley Pediatrics Provo Utah 84604 —
PI-Coor Clinical Research, LLC Burke Virginia 22015 —
Advanced Pediatrics Vienna Virginia 22180 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00344305, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 24, 2017 · Synced Oct 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00344305 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →